학술논문

PERSIST-1: A PHASE III STUDY OF PACRITINIB (PAC) VS BEST AVAILABLE THERAPY (BAT) IN PRIMARY MYELOFIBROSIS (PMF), POST-POLYCYTHEMIA VERA MF (PPV-MF) OR POST-ESSENTIAL THROMBOCYTHEMIA MF (PET-MF)
Document Type
Journal
Source
HAEMATOLOGICA; JUN 2015, 100 p103-p103, 1p. Supplement: 1
Subject
Language
English
ISSN
03906078